What’s the Problem?
This FDA Recall began on September 24, 2020, and affects 1 lot (747 cartons) of RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level.
Manufactured by Sun Pharmaceutical Industries, the recalled metformin is used to improve glycemic control in patients with type 2 diabetes mellitus.
RIOMET ER is packaged in 16 oz. (473 mL) round bottles labeled with the NDC Number 10631-019-17 and an Expiration Date of 10/2021. Each carton contains one bottle of drug pellets, one bottle of diluent, and one dosing cup.
This recall was initiated after FDA testing revealed N-Nitrosodimethylamine (NDMA) levels above the allowable Acceptable Daily Intake (ADI). Animal studies have linked NDMA to liver, lung, and kidney cancer. The World Health Organization (WHO) says it can also cause gastric or colorectal cancer.
Consumers who were prescribed any recalled Riomet should continue taking the medication as directed and contact their doctor immediately regarding an alternative treatment.
Do I Have a Riomet Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Riomet Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one was harmed by a recalled metformin drug, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.